GlassScriptPhysician profile
John Sacco
NPI 1336133685
$291.28
in general payments reported to CMS, 2019-2025
12 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $41.34 · 2023: $23.25 · 2024: $116 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $249.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $38.81 | 2025 | Zoladex |
| Sumitomo Pharma America, INC. | $33.76 | 2024-2025 | Orgovyx |
| Jazz Pharmaceuticals INC. | $30.00 | 2025 | |
| Genzyme Corporation | $27.27 | 2022 | |
| Janssen Biotech, INC. | $26.80 | 2024 | Talvey, Tecvayli, Darzalex |
| Stemline Therapeutics INC. | $25.00 | 2025 | Orserdu |
| Tactile Systems Technology INC | $23.25 | 2023 | Entre Plus, Flexitouch Plus |
| Progenics Pharmaceuticals, INC. | $20.10 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $18.94 | 2024 | Libtayo |
| Bayer Healthcare Pharmaceuticals INC. | $18.60 | 2024 | |
| Tempus Ai, INC | $14.68 | 2024 | |
| Lilly USA, LLC | $14.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sacco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.